Randomized Controlled Trials
The gold standard for causal evidence
A randomized controlled trial (RCT) randomly allocates participants to an intervention or control group and compares outcomes to test causal claims with the highest internal validity. Randomization balances both known and unknown confounders, making RCTs the strongest single design for evaluating whether an intervention causes its intended effect. Reporting follows the CONSORT guideline.
Definition of the Concept
A randomized controlled trial is an experimental research design in which participants are assigned by chance to at least one intervention group and one control group. The control condition may be a placebo, standard care, or no intervention. The core logic is that randomization eliminates systematic differences between groups, so any observed difference in outcomes can be attributed to the intervention itself. This causal power makes RCTs the preferred design in clinical, educational, and social policy research.
How It Works: Steps and Types
An RCT typically proceeds through these steps: (1) Define eligibility criteria and recruit participants; (2) Randomize — using simple, stratified, cluster, or block randomization; (3) Apply allocation concealment so that group assignment cannot be foreseen or manipulated; (4) Implement blinding of participants, practitioners, or outcome assessors; (5) Measure and analyze outcomes. The main RCT types include parallel-group, crossover, and factorial designs, each suited to different research questions and practical constraints.
A Concrete Example
A researcher testing a new anxiety treatment randomly assigns 200 participants via computer-generated allocation to two groups: one receives eight weeks of cognitive-behavioral therapy while the other remains on a waiting list. Allocation concealment is ensured with sealed envelopes, and outcome assessors are kept blind to group membership. At week eight, anxiety scores are compared between groups; any observed difference can be attributed to the intervention because randomization has balanced other variables across conditions.
Common Pitfalls and Best Practices
Randomization alone is insufficient; without allocation concealment, selection bias can undermine internal validity. When blinding is impractical (e.g., surgical interventions), this limitation must be transparently reported. High attrition threatens internal validity; intention-to-treat analysis mitigates this risk. Sample size must be determined a priori through power analysis. Reporting should follow the CONSORT 2010 flow diagram and checklist, and all pre-registered primary outcomes must be reported in the order they were specified.
Key terms
- Randomization
- Chance-based assignment of participants to groups; balances known and unknown confounders.
- Allocation Concealment
- Hiding group assignment until after enrollment; prevents selection bias before randomization.
- Blinding
- Keeping participants, practitioners, or assessors unaware of group assignment to reduce bias.
- Intention-to-Treat Analysis
- Analyzing all randomized participants in their assigned group regardless of protocol adherence.
- CONSORT
- International standard guideline and checklist for transparent reporting of randomized trials.
Further reading
- Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. DOI: 10.1136/bmj.c332 ↗